Extracellular matrix×Computational biology

Extracellular matrix biology remains a descriptive, wet-lab-dominated field despite driving cancer metastasis, fibrosis, and wound healing — while computational biology has just crossed a threshold in predicting protein structure, interaction networks, and multi-scale tissue models. Fusing them turns the ECM from a poorly-parameterized 'black box' into a computable system, enabling predictive models of matrix remodeling, protein-matrix binding, and tumor microenvironment dynamics.

The two communities barely co-publish (recent-share on Field A is literally 0.0), but they already share a dense scaffold of bridge fields — Organoid, Kidney, Cell culture, In vivo, Extracellular — that are exactly the systems where ECM matters and where computation is being applied. 52 authors already publish on both sides separately, and an Adamic-Adar affinity of 7.22 with 27 common neighbours signals a structurally 'ready' but not-yet-fired connection. The catalyst is that ECM proteins (collagens, laminins, fibronectin) are large, glycosylated, and disordered — precisely the class AlphaFold-era tooling and network methods are now beginning to reach.

Winners will be groups that already sit on a bridge field — organoid/kidney/microenvironment labs with in-house computational muscle — rather than pure ECM biologists or pure ML groups. Specifically, tumor-microenvironment and tissue-engineering labs that can generate proprietary matrix proteomics/imaging data AND run structure-prediction or graph-network pipelines will convert first, because the bottleneck is joint data, not either skill alone.

Build a predictive model of ECM remodeling in the tumor microenvironment by pairing spatial proteomics of collagen/laminin/MMP activity in patient-derived organoids with structure-prediction and graph-based interaction networks — then validate predicted matrix-protein binding events against perturbation experiments in the same organoid system. The deliverable: an open, parameterized 'computable ECM' interaction map benchmarked on kidney and tumor organoids.